Christopher D. Fjell
- Microbiology top 0.05%
- Antimicrobial Peptides and Activities 15
- Immunology top 5%
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 3
- Molecular Biology top 2%
- Biochemical and Structural Characterization 11
- vaccines and immunoinformatics approaches 5
- Chemical Synthesis and Analysis 5
- Molecular Medicine top 5%
-
- Sepsis Diagnosis and Treatment 11
-
- SARS-CoV-2 and COVID-19 Research 4
Christopher D. Fjell
46 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Microbiology 2.5k
- Immunology 890
- Molecular Biology 2.6k
- Molecular Medicine 145
- Critical Care and Intensive Care Medicine 124
Countries citing papers authored by Christopher D. Fjell
This map shows the geographic impact of Christopher D. Fjell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Fjell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Fjell more than expected).
Fields of papers citing papers by Christopher D. Fjell
This network shows the impact of papers produced by Christopher D. Fjell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Fjell. The network helps show where Christopher D. Fjell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher D. Fjell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 7 | |
| 4 | 2016 | 106 | |
| 5 | 2016 | 30 | |
| 6 | 2016 | 30 | |
| 7 | 2016 | 82 | |
| 8 | 2015 | 19 | |
| 9 | 2014 | 152 | |
| 10 | 2014 | 6 | |
| 11 | 2014 | 107 | |
| 12 | 2014 | 5 | |
| 13 | 2013 | 56 | |
| 14 | 2013 | 77 | |
| 15 | Designing antimicrobial peptides: form follows functionbreakdown → | 2011 | 1608 |
| 16 | 2010 | 72 | |
| 17 | 2009 | 180 | |
| 18 | 2007 | 57 | |
| 19 | 2007 | 84 | |
| 20 | 2007 | 37 |
About Christopher D. Fjell
Christopher D. Fjell is a scholar working on Microbiology, Immunology and Family Practice, having authored 46 papers that have together received 4.7k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (15 papers), Biochemical and Structural Characterization (11 papers), Sepsis Diagnosis and Treatment (11 papers), Immune Response and Inflammation (6 papers), vaccines and immunoinformatics approaches (5 papers), Chemical Synthesis and Analysis (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Microbiology (2.5k citations), Immunology (890 citations) and Molecular Biology (2.6k citations). Christopher D. Fjell has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Robert E. W. Hancock, Gisbert Schneider, Jan A. Hiss, Artem Cherkasov, Håvard Jenssen, John H. Boyd, Kai Hilpert, Keith R. Walley, Olga M. Pena and James A. Russell. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.